Email updates

Keep up to date with the latest news and content from WJSO and BioMed Central.

Open Access Highly Accessed Case report

Desmoid tumors of the abdominal wall: A case report

Marcus Overhaus1*, Pan Decker1, Hans Peter Fischer2, Hans Jochen Textor3 and Andreas Hirner1

Author Affiliations

1 Department of General-, Visceral-, Thoracic- and Vascular Surgery, Sigmund Freud Str. 25, 53105 Bonn, University of Bonn, Germany

2 Department of Pathology, Sigmund Freud Str. 25, 53105 Bonn, University of Bonn, Germany

3 Department of Radiology, Sigmund Freud Str. 25, 53105 Bonn, University of Bonn, Germany

For all author emails, please log on.

World Journal of Surgical Oncology 2003, 1:11  doi:10.1186/1477-7819-1-11


The electronic version of this article is the complete one and can be found online at: http://www.wjso.com/content/1/1/11


Received:16 April 2003
Accepted:9 July 2003
Published:9 July 2003

© 2003 Overhaus et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

Abstract

Background

Desmoid tumors are slow growing deep fibromatoses with aggressive infiltration of adjacent tissue but without any metastatic potential.

Case Presentation

We report on two female patients with desmoid tumor of the abdominal wall who underwent primary resection. Both patients had a history of an earlier abdominal surgery. Preoperative evaluation included abdominal ultrasound, magnetic resonance imaging and computed tomography. The histology in both cases revealed a desmoid tumor.

Conclusion

Complete surgical resection is the first line management of this tumor entity.

Keywords:
Desmoid; fibromatosis; abdominal; genotype; familial adenomatous polyposis; clonal neoplasm; surgery.

Background

Desmoid tumors are benign myofibroblastic neoplasms originating from the muscle aponeurosis and classified as deep fibromatoses [1]. They constitute 3% of all soft tissue tumors and 0.03% of all neoplasms [2]. Despite their aggressive local infiltration, desmoid tumors lack a metastatic potential [3]. However, because of this local infiltration and compression of surrounding structures, a high recurrence rate exists and in anatomic locations with restricted access to surgical resection desmoid tumors can lead to death [4]. Especially in patients with familial adenomatous polyposis (FAP) undergoing colectomy desmoid tumors are the leading cause of morbidity and mortality [5].

Molecular studies demonstrated desmoid tumors in FAP as clonal neoplasms arising from germline mutation or changes in the APC alleles [6-8]. Cytogenic data verified clonal chromosome aberrations in deep-seated sporadic extra-abdominal fibromatoses and lesions of the abdominal wall and therefore provide additional evidence for the neoplastic nature of these lesions [9].

Main locations of desmoid tumor occurrence are the proximal extremities, the abdominal wall and the mesenteric intestine in patients with FAP [10]. In sporadic cases, they occur in localisations of trauma, and scars or irradiation. The therapeutic management of these tumors is still controversial.

Case Presentation

Case 1

A 28-year-old female recognized a left lower abdominal wall tumor. In her history she reported an appendectomy and two pregnancies with spontaneous birth in 1994 and 1999. On clinical admission, a painless tumor was investigated without any contact to hip bone structures. Analysed blood parameters were within normal range and tumor markers were negative.

Preoperative computed tomography scan (CT, figure 1) and magnet-resonance-tomography (MRT, figure 2) revealed a left lower abdominal wall tumor of unknown dignity. The MRT morphology demonstrated a fibrotic tumor, originating from the transversal and internal oblique abdominal muscle fascia. The resection of the tumor with excision of the oblique internal abdominal muscle followed and the defect was covered with a Bard Composix-Mesh® (C. R. Bard, Inc., 730 Central Aves Murray Hill, New Jersey, 07974, USA) and major omentum.

thumbnailFigure 1. CT Scan with contrast enhancement demonstrates the desmoid tumor originating from the abdominal transversal and internal oblique muscle fascia with inhomogeneous formation (arrow bar).

thumbnailFigure 2. MRT shows the tumor's location embedded in the adjacent musculature. The hypointense parts of the tumor indicate the high mucoid proportion (arrow bar).

The postoperative course was uneventful and the patient was discharged at the 8th postoperative day.

Case 2

A 37-year-old female recognized an initially painless tumor in the right lower abdominal wall. In her history, the patient reported on a laparoscopic resection of an ovarian-cyst in 1993 and two pregnancies (1995 and 1997) with caesarean section. On admission, a palpable demarcated fixed tumor in the right lower third of the lateral abdominal wall was investigated. Analysed blood parameters were within normal range and tumor markers negative.

The CT revealed an ovarian-tumor, combined with a right abdominal wall tumor of unknown dignity. A metastasis of the ovarian-tumor, a lymphoma or a sarcoma was discussed as differential diagnosis. The MRT demonstrated the abdominal wall tumor originating from the abdominal transversal muscle and internal abdominal oblique muscle fascia. First, extirpation of the right ovary was performed. The resection of the abdominal wall tumor included the excision of the internal abdominal oblique muscle, replaced by a Bard Composix-Mesh® and covered with major omentum.

The postoperative course was uneventful and the patient was discharged at the 9th postoperative day.

Histological examination Case 1 and 2

Microscopic examination of the resected specimen in both the cases revealed the spindle-cellular tumors immigrated through muscle-tissues consisting of partially intact musclefibers surrounded by spindle like elements. Tumor-cells had a pale eosinophilic cytoplasm and chromatin structures and were embedded in collagen network interrupted by fibrotic sections (Figure 3). The immunohistochemistry revealed a minority of spindled tumor cells, expressing smooth muscle cell actin. Lower than 3% of the tumor-cells expressed the proliferative Ki 67 antigen. A desmoid tumor was diagnosed in both cases (figure 4).

thumbnailFigure 3. Layers of tumor cells with pale eosinophilic cytoplasm and nuclei and sporadic mitoses characterize the histological picture.

thumbnailFigure 4. The desmoid tumor is macroscopically composed of a well-defined capsule infiltrated by a collagen network with fibrotic sections.

Sections from the ovary in case 2 revealed a demarcated, non capsulated, spindle-cellular, collagen rich tumor a diagnosis of an ovarian fibroma without signs of malignancy was made.

Discussion

Desmoid tumors are benign deep fibromatoses, originating from fascia and muscle aponeurosis with an infiltrating growth [11]. They are primary located abdominally or intraabdominally [1], whereas only sporadic cases describe a localisation within the thorax wall [12] or retroperitoneally [13]. The desmoid tumor is often associated with female gender, FAP [14] and occasionally with surgical trauma [15]. It has a higher prevalence in women who experienced pregnancy [16]. Depending on the tumors size, on the therapy and on the negative resection margins, recurrence occurs in up to 45% [17].

CT scan localizes the tumor and excludes metastasis (figure 1). MRT reveals the tumor's hypointensity on T1 and demonstrates variable signal intensity on T2 weighted imaging, depending on the accumulation of mucoid structures (figure 2). Therefore, a differentiation from other solid tumors is impossible using morphological criteria [18]. Histology is the only evidentiary method which demonstrates long fascicles of spindle cells of variable cell-density with few mitoses and absence of atypical nucleus-separations (figure 3). Characteristically, there is a diffuse cell infiltration of adjacent tissue structures. Immunohistochemical response for actin can be partially positive and immunohistochemical muscle cell markers delimit desmoid tumors from fibrosarcoma [19].

The therapy of choice is still controversial [20]. Anti-inflammatory treatment [21], hormone-therapy [22] and chemotherapy [23] were not shown to be effective. These therapies are limited to patients, in whom resection is technically impossible because of a widespread tumor infiltration.

The effectiveness and indication of initial and adjuvant radiation is not proven yet. In a comparative analysis, a significantly better local recurrence control was described with radiation and combined surgical resection in comparison to resection only [17]. However, these results of radiation therapy can only be achieved due to a higher complication rate [24]. Other studies show a tumor progress after radiation therapy [25] and a high local recurrence rate [26].

Due to the germline mutations and chromosomal aberrations of the APC alleles Bright-Thomas et al. performed a pre-clinical study of gene transfer for the treatment of desmoid disease in FAP [27]. Despite the success of transgene expression, further work is needed in animal models of desmoid disease to assess the clinical effects of gene therapy.

Therefore, the most effective treatment of accessible and smaller desmoid tumors is still the resection with negative margins, although it may not prevent local recurrence [4]. However, massive mesenteric lesions often occur in FAP patients after colectomy [5] and non surgical treatment has variable and unpredictable objective efficacy [10,21,28,29]. Middleton et al. reported on successful short-term surgery in four cases of large intra-abdominal tumors in which non-surgical treatment was inefficient [28]. In conclusion, there remains a need for a wider range of therapeutic options, especially in the management of these massive tumors.

Surgery always aims at radical tumor resection with free margins, which, depending on localisation of surgery, may leave major soft tissue defects behind [28,30,31]. Although abdominal wall integrity after full-thickness surgery can be restored with direct sutures [4,32], reconstruction with synthetic materials is a common technique in major abdominal wall defects [33]. Albeit in our study the small tumor resection with tumor free margins and reconstruction of the abdominal wall was performed with a Bard Composix-Mesh® (figure 5), recent literature data recommend distant or free muscle flaps for greater abdominal wall defect coverage that is not accessible to local flaps [30,32]. Additionally, prosthetic material is more susceptible to bacterial infection and other complications [34,35], although new developed material showed encouraging experimental results [36].

thumbnailFigure 5. After resection of the desmoid tumor the abdominal wall defect is replaced with a Bard Composix-Mesh®.

In conclusion, the treatment of desmoid tumors remains enigmatic. Non-surgical treatment resulted in diverse and unpredictable outcome and is considered to be an opportunity in patients with unresectable lesions or for adjuvant therapy. Radical resection with clear margins remains the principal determinant of outcome with the risk of local recurrence.

Abbreviations

computed tomography scan (CT), magnet-resonance-tomography (MRT), familial adenomatous polyposis (FAP)

Competing interests

None declared.

Authors' contributions

MO participated in the preparation of the manuscript, literature search and drafted the manuscript.

PD was responsible for the operations, follow-up of the patients and data preparation and conceived of the study.

HPF carried out the tissue preparation, (immuno)histology and edited the manuscript for its scientific content.

HJT accomplished and analysed the CT scans and MRT and approved the final version of the manuscript.

AH participated in its design and coordination.

All authors read and approved the final manuscript.

References

  1. Fletcher CDM: Myofibroblastic tumours: an update.

    Verh Dtsch Ges Path 1998, 82:75-82. OpenURL

  2. Kiel KD, Suit HD: Radiation therapy in the treatment of aggressive fibromatoses (desmoid tumors).

    Cancer 1984, 54:2051-2055. PubMed Abstract OpenURL

  3. Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brennan MF: The enigma of desmoid tumors.

    Ann Surg 1999, 229:866-872. PubMed Abstract | Publisher Full Text OpenURL

  4. Merchant NB, Lewis JJ, Woodruff JM, Leung DH, Brennan MF: Extremity and trunk desmoid tumors: a multifactorial analysis of outcome.

    Cancer 1999, 86:2045-2052. PubMed Abstract | Publisher Full Text OpenURL

  5. Nugent KP, Spigelman AD, Phillips RK: Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis.

    Dis Colon Rectum 1993, 36:1059-1062. PubMed Abstract OpenURL

  6. Dangel A, Meloni AM, Lynch HT, Sandberg AA: Deletion (5q) in a desmoid tumor of a patient with Gardner's syndrome.

    Cancer Genet Cytogenet 1994, 78:94-98. PubMed Abstract | Publisher Full Text OpenURL

  7. Miyaki M, Konishi M, Kikuchi-Yanoshita R, Enomoto M, Tanaka K, Takahashi H, Muraoka M, Mori T, Konishi F, Iwama T: Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis.

    Cancer Res 1993, 53:5079-5082. PubMed Abstract OpenURL

  8. Palmirotta R, Curia MC, Esposito DL, Valanzano R, Messerini L, Ficari F, Brandi ML, Tonelli F, Mariani-Costantini R, Battista P: Novel mutations and inactivation of both alleles of the APC gene in desmoid tumors.

    Hum Mol Genet 1995, 4:1979-1981. PubMed Abstract OpenURL

  9. de Wever I, Dal Cin P, Fletcher CD, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van den Berghe H, Vanni R, Willen H: Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. CHromosomes And Morphology.

    Mod Pathol 2000, 13:1080-1085. PubMed Abstract OpenURL

  10. Lynch HT, Fitzgibbons R, Jr: Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature review.

    Am J Gastroenterol 1996, 91:2598-2601. PubMed Abstract OpenURL

  11. Hasegawa SL, Fletcher CDM: Fibromatosis in the adult.

    Adv Pathol 1996, 9:259-275. OpenURL

  12. Gacouin A, Desrues B, Lecoz A, Quinquenel ML, Ramee MP, Delaval P: [Desmoid tumor of the thoracic wall].

    Rev Mal Respir 1993, 10:554-556. PubMed Abstract OpenURL

  13. Budzynski A, Wysocki A: [Retroperitoneal desmoid tumor].

    Przegl Lek 1996, 53:506-507. PubMed Abstract OpenURL

  14. Soravia C, Berk T, McLeod RS, Cohen Z: Desmoid disease in patients with familial adenomatous polyposis.

    Dis Colon Rectum 2000, 43:363-369. PubMed Abstract OpenURL

  15. De Cian F, Delay E, Rudigoz RC, Ranchere D, Rivoire M: Desmoid tumor arising in a cesarean section scar during pregnancy: monitoring and management.

    Gynecol Oncol 1999, 75:145-148. PubMed Abstract | Publisher Full Text OpenURL

  16. Gansar GF, Markowitz IP, Cerise EJ: Thirty years of experience with desmoid tumors at Charity Hospital.

    Am Surg 1987, 53:318-319. PubMed Abstract OpenURL

  17. Nuyttens JJ, Rust PF, Thomas CR, Jr, Turrisi AT,III: Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles.

    Cancer 2000, 88:1517-1523. PubMed Abstract | Publisher Full Text OpenURL

  18. Casillas J, Sais GJ, Greve JL, Iparraguirre MC, Morillo G: Imaging of intra- and extraabdominal desmoid tumors.

    Radiographics 1991, 11:959-968. PubMed Abstract OpenURL

  19. Mentzel T, Katenkamp D: [Myofibroblastic tumors. Brief review of clinical aspects, diagnosis and differential diagnosis].

    Pathologe 1998, 19:176-186. PubMed Abstract | Publisher Full Text OpenURL

  20. Shields CJ, Winter DC, Kirwan WO, Redmond HP: Desmoid tumours.

    Eur J Surg Oncol 2001, 27:701-706. PubMed Abstract | Publisher Full Text OpenURL

  21. Waddell WR, Kirsch WM: Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors.

    Am J Surg 1991, 161:416-421. PubMed Abstract OpenURL

  22. Wilcken N, Tattersall MH: Endocrine therapy for desmoid tumors.

    Cancer 1991, 68:1384-1388. PubMed Abstract OpenURL

  23. Patel SR, Evans HL, Benjamin RS: Combination chemotherapy in adult desmoid tumors.

    Cancer 1993, 72:3244-3247. PubMed Abstract OpenURL

  24. Goy BW, Lee SP, Eilber F, Dorey F, Eckardt J, Fu YS, Juillard GJ, Selch MT: The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors.

    Int J Radiat Oncol Biol Phys 1997, 39:659-665. PubMed Abstract | Publisher Full Text OpenURL

  25. Rock MG, Pritchard DJ, Reiman HM, Soule EH, Brewster RC: Extra-abdominal desmoid tumors.

    J Bone Joint Surg Am 1984, 66:1369-1374. PubMed Abstract OpenURL

  26. Pritchard DJ, Nascimento AG, Petersen IA: Local control of extra-abdominal desmoid tumors.

    J Bone Joint Surg Am 1996, 78:848-854. PubMed Abstract | Publisher Full Text OpenURL

  27. Bright-Thomas RM, Agrawal A, Hargest R: Preclinical studies of gene transfer for the treatment of desmoid disease in familial adenomatous polyposis.

    Br J Surg 2002, 89:1563-1569. PubMed Abstract | Publisher Full Text OpenURL

  28. Middleton SB, Phillips RK: Surgery for large intra-abdominal desmoid tumors: report of four cases.

    Dis Colon Rectum 2000, 43:1759-1762. PubMed Abstract OpenURL

  29. Okuno SH, Edmonson JH: Combination chemotherapy for desmoid tumors.

    Cancer 2003, 97:1134-1135. PubMed Abstract | Publisher Full Text OpenURL

  30. Brenner P, Rammelt S: Abdominal wall and foot reconstruction after extensive desmoid tumor resection with free tissue transfer.

    Langenbecks Arch Surg 2002, 386:592-597. PubMed Abstract | Publisher Full Text OpenURL

  31. Sutton RJ, Thomas JM: Desmoid tumours of the anterior abdominal wall.

    Eur J Surg Oncol 1999, 25:398-400. PubMed Abstract | Publisher Full Text OpenURL

  32. Rohrich RJ, Lowe JB, Hackney FL, Bowman JL, Hobar PC: An algorithm for abdominal wall reconstruction.

    Plast Reconstr Surg 2000, 105:202-216. PubMed Abstract | Publisher Full Text OpenURL

  33. Bauer JJ, Salky BA, Gelernt IM, Kreel I: Repair of large abdominal wall defects with expanded polytetrafluoroethylene (PTFE).

    Ann Surg 1987, 206:765-769. PubMed Abstract OpenURL

  34. Disa JJ, Klein MH, Goldberg NH: Advantages of autologous fascia versus synthetic patch abdominal reconstruction in experimental animal defects.

    Plast Reconstr Surg 1996, 97:801-806. PubMed Abstract OpenURL

  35. Leber GE, Garb JL, Alexander AI, Reed WP: Long-term complications associated with prosthetic repair of incisional hernias.

    Arch Surg 1998, 133:378-382. PubMed Abstract | Publisher Full Text OpenURL

  36. Disa JJ, Chiaramonte MF, Girotto JA, Klein MH, Goldberg NH: Advantages of autologous fascia versus synthetic patch abdominal reconstruction in experimental animal defects.

    Plast Reconstr Surg 2001, 108:2086-2087. PubMed Abstract | Publisher Full Text OpenURL